CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 91 filers reported holding CUE BIOPHARMA INC in Q3 2021. The put-call ratio across all filers is 0.43 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $29,000 | -57.4% | 6,007 | 0.0% | 0.00% | – |
| Q4 2021 | $68,000 | -41.9% | 6,007 | -25.1% | 0.00% | – |
| Q3 2021 | $117,000 | +1571.4% | 8,016 | +1164.4% | 0.00% | – |
| Q2 2021 | $7,000 | -12.5% | 634 | 0.0% | 0.00% | – |
| Q1 2021 | $8,000 | -20.0% | 634 | -23.5% | 0.00% | – |
| Q4 2020 | $10,000 | -16.7% | 829 | 0.0% | 0.00% | – |
| Q3 2020 | $12,000 | -40.0% | 829 | 0.0% | 0.00% | – |
| Q2 2020 | $20,000 | – | 829 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Corriente Advisors, LLC | 1,915,219 | $23,959,000 | 5.70% |
| Prosight Management, LP | 906,569 | $11,341,000 | 5.24% |
| P.A.W. CAPITAL CORP | 140,000 | $1,751,000 | 1.54% |
| Voss Capital, LLC | 220,714 | $2,761,000 | 1.39% |
| Robertson Stephens Wealth Management, LLC | 484,000 | $6,054,000 | 1.26% |
| Slate Path Capital LP | 1,483,619 | $18,560,000 | 1.00% |
| Nantahala Capital Management | 2,506,772 | $31,360,000 | 0.97% |
| PRECEPT MANAGEMENT LLC | 150,000 | $1,877,000 | 0.76% |
| SANDERS MORRIS HARRIS LLC | 193,591 | $2,449,000 | 0.56% |
| Rock Creek Group, LP | 100,014 | $1,251,000 | 0.51% |